Process- and product-related impurities in the ChAdOx1 nCov-19 vaccine
ChAdOx1 nCov-19 and Ad26.COV2.S are approved vaccines inducing protective immunity against SARS-CoV-2 infection in humans by expressing the Spike protein of SARS-CoV-2. We analyzed protein content and protein composition of ChAdOx1 nCov-19 and Ad26.COV2.S by biochemical methods and by mass spectrome...
Asıl Yazarlar: | , , , , , |
---|---|
Materyal Türü: | Makale |
Dil: | English |
Baskı/Yayın Bilgisi: |
eLife Sciences Publications Ltd
2022-07-01
|
Seri Bilgileri: | eLife |
Konular: | |
Online Erişim: | https://elifesciences.org/articles/78513 |